Outsourced Pharma Capacity Update Videos - Small Molecule

  1. MilliporeSigma Capacity Update July 2025: Small Molecule Drug Substance/API 7/29/2025

    Applications specialist John Stevens shows how MilliporeSigma is using their 35+ years of CDMO experience and expertise to move customers’ small molecules forward to the clinic and beyond to commercialization.

  2. Amorphous Solid Dispersions: Pre-Clinical To Commercial Capabilities 7/29/2025

    ASDs continue to be an attractive option for progressing and commercializing poorly soluble compounds. This talk focuses on capabilities to screen the potential for ASDs in early phase studies as well as their commercial applicability.

  3. Your Integrated Drug Substance Partner 7/29/2025

    With capabilities to support your next small molecule drug substance program from R&D to commercial scale, learn about our integrated facilities, project teams, and available capacity.

  4. Aragen Capacity Update July 2025: Small Molecule Drug Substance/API 7/28/2025

    Explore specialized expertise in solving challenging small molecule formulation problems (poor solubility, bioavailability, complex delivery routes).

  5. Cambrex Capacity Update April 2025: Small Molecule 4/23/2025

    Chief Scientific Officer of Cambrex and President of Snapdragon Chemistry, Matthew Bio, Ph.D., presents the company’s capabilities in the development of peptide therapeutics.

  6. Bend Bioscience Capacity Update April 2025: Small Molecule 4/23/2025

    Leverage expert small molecule solutions from preclinical development to commercial manufacturing, with strengths in large-scale oral solids, advanced formulations, and more.

  7. SK pharmteco Capacity Update April 2025: Small Molecule 4/23/2025

    Join Nicholas Duda, Executive Director of Business Development, as he highlights our available capacity across North America, Europe, and Asia, and our unique capabilities.

  8. Ropack Pharma Solutions Capacity Update April 2025: Small Molecule 4/23/2025

    Learn how our nearly 50 years of expertise in oral solid dosage manufacturing and packaging can support your project with cutting-edge services and expanding capacity to meet your needs.

  9. Upperton Pharma Solutions Capacity Update January 2025: Small Molecule 1/29/2025

    Gain insight into the capabilities of our award-winning development and manufacturing facility, which features 10 state-of-the-art GMP manufacturing suites integrated with cutting-edge R&D and QC laboratories.

  10. Douglas CDMO Capacity Update January 2025: Small Molecule 1/29/2025

    By leveraging our extensive experience, flexible capabilities, and client-focused approach, we help our partners accelerate time-to-market and achieve successful outcomes for their therapies.